文献速递关节外科创伤骨科

翻修全膝关节置换术后阿片类药物使用时长随翻修原因显著不同

Duration of Opioid Use Following Revision Total Knee Arthroplasty Varies Significantly With Reason for Revision.
PubMed 文献 · J Arthroplasty · 2026-04-24

本研究回顾性分析164例翻修全膝关节置换(TKA)患者并与年龄性别匹配的初次TKA对照组比较,发现翻修患者住院期间吗啡毫克当量(MME)更高,但初次TKA患者术后阿片类药物使用持续时间更长;翻修原因显著影响术后3个月内阿片类药物配药数量及使用时长,假体周围股骨骨折平均使用天数最长。

要点

  • 翻修TKA患者住院期间MME显著高于初次TKA患者(P=0.003)。
  • 初次TKA患者术后阿片类药物使用持续时间长于翻修患者(P=0.006)。
  • 翻修原因显著影响术后3个月内阿片类药物配药数量及使用时长(P=0.0001和P=0.04)。

核心结论

  • 因关节纤维化或假体周围股骨骨折行翻修TKA的患者需要更密集的疼痛管理。
  • 翻修病因可指导术后疼痛管理策略的个体化制定,以优化恢复和阿片类药物使用。

研究设计与样本

  • 回顾性研究,纳入164例翻修TKA患者,并与年龄和性别匹配的初次TKA对照组比较。
  • 收集并计算处方阿片类药物数量、住院期间MME、总MME及从手术至末次阿片类药物配药的 Days。
  • 确定翻修原因和翻修TKA类型,收集合并症并计算Charlson合并症指数(CCI)。
  • 所有统计检验显著性水平设为P≤0.05。

主要发现

  • 翻修TKA患者住院期间MME显著高于初次TKA患者(P=0.003)。
  • 初次TKA患者从手术至末次阿片类药物配药的天数长于翻修患者(P=0.006)。
  • 翻修TKA患者使用抗抑郁药和苯二氮䓬类药物的比例高于初次TKA患者(P=0.036和P=0.003)。
  • 急性感染和感染第一阶段间隔物植入的住院期间MME最高(>200 MME)。
  • 术后3个月内阿片类药物配药数量及术后阿片类药物使用时长随翻修原因显著不同(P=0.0001和P=0.04),假体周围股骨骨折平均天数最长且需要延长阿片类药物使用。

临床怎么用

  • 根据翻修病因(如关节纤维化、假体周围股骨骨折)识别需要更密集疼痛管理的患者。
  • 针对关节纤维化患者术后僵硬和康复需求增加、假体周围骨折患者骨折疼痛和负重限制,个体化调整术后疼痛管理策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Few studies have evaluated postoperative opioid use after revision total knee arthroplasty (TKA). The primary objective of this study was to evaluate postoperative opioid (in-hospital and outpatient) use in revision TKA. METHODS: A retrospective review of 164 revision TKA patients that were age- and sex-matched to a primary TKA control group was conducted. The number of opioids prescribed, in-hospital morphine milligram equivalents (MME), total MME, and days between surgery and last date an opioid was dispensed were collected and calculated. Reason for revision TKA and type of revision TKA performed were determined. Medical comorbidities were collected and the Charlson Comorbidity Index (CCI) was calculated. Significance for all statistical tests was accepted at P ≤ 0.05. RESULTS: Revision TKA patients had significantly higher in-hospital MME compared to primary TKA patients (P = 0.003). Primary TKA patients had a longer duration between surgery and the last date an opioid was dispensed versus revision patients (P = 0.006). A higher percentage of revision TKA patients used anti-depressants and benzodiazepines compared to primary TKA patients (P = 0.036 and P = 0.003, respectively). Acute infection and infection stage 1 spacer implantation demonstrated the highest in-hospital MME (> 200 MME). The number of opioids sold within three months post-operation and the duration of opioid use post-surgery varied significantly depending on the revision reason (P = 0.0001 and P = 0.04). Periprosthetic femur fracture had the highest mean days and required extended opioid use. CONCLUSIONS: Revision TKA for arthrofibrosis and periprosthetic femur fractures required more intensive pain management, likely due to post-operative stiffness and increased rehabilitation demands for arthrofibrosis patients and fracture-related pain and weight-bearing restrictions for periprosthetic fracture patients, respectively. This information can help tailor postoperative pain management strategies based on the etiology of revision, to optimize patient recovery and opioid use.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Barton KI, Salimi M, Rosen NF, et al. Duration of Opioid Use Following Revision Total Knee Arthroplasty Varies Significantly With Reason for Revision. J Arthroplasty. 2026. PMID: 42036083. doi:10.1016/j.arth.2026.04.069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。